Lodz, Poland
Research view
Type 1 diabetes: who works on it
Groups that published on this disease or run trials on it, from public registries and publications. Researchers appear by name only once their profile is published.
Find fellow researchers
One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.
- All targets
- GLP-1 20
- SGLT2 12
- NRF2 0
- CTLA-4 0
- STAT3 0
- AKT 0
- GIP 2
- PD-1 0
- SIRT1 0
- CD40 0
- PPAR 0
- TP53 0
- JAK 1
- JNK 0
- mTOR 0
- NLRP3 1
- TLR4 0
- AMPK 0
- DPP-4 0
- IL-6 0
- TNF 0
- IL-1 0
- IL-17 0
- MAPK 0
- PI3K 0
- VEGF 1
- CD47 0
- HMGB1 0
- PD-L1 0
- ACE2 0
- BDNF 0
- CD19 0
- CD20 1
- CD38 0
- ERK 0
- FOXP3 0
- G6PD 0
- IL-13 0
- IL-4 0
- PCSK9 0
- RANKL 0
- STING 0
- TIGIT 0
- AR 0
- B7-H3 0
- CD22 0
- CTNNB1 0
- CXCR4 0
- EGFR 0
- GPX4 0
- HDAC 0
- HER2 0
- HER3 0
- HSP90 0
- IGF1R 0
- LAG-3 0
- METTL3 0
- MYC 0
- NMDA 0
- PDGFR 0
EU-13 is a filter, not a ranking: it only narrows the list.
1 of 1+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.
Trials that share participant data
Trials whose registry record says individual participant data (IPD) will be shared.
No trial in this view states that it shares participant data.
Search by method
Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.
- Single-Cell Analysis 10
- Organoids 4
- Mendelian Randomization Analysis 35
- CRISPR-Cas Systems 5
- Gene Expression Profiling 34
- Sequence Analysis, RNA 3
- Whole Genome Sequencing 1
- Exome Sequencing 3
- Proteomics 20
- Metabolomics 15
- Mass Spectrometry 4
- Flow Cytometry 12
- Immunohistochemistry 16
- Positron-Emission Tomography 3
- Magnetic Resonance Imaging 33
- Machine Learning 31
- Deep Learning 10
- Cohort Studies 158
- Genome-Wide Association Study 54
Flow Cytometric Immune Profiling Enables Early Detection of Rejection in Islet Xenotransplantation.
Changes in circulating NK and innate-like T cells in type 1 and type 2 diabetes.
Prevention and treatment of diabetes with resveratrol in a non-obese mouse model of type 1 diabetes.
Interaction of vitamin D receptor with HLA DRB1 0301 in type 1 diabetes patients from North India.
Paste an abstract
See which targets of this disease your abstract mentions, and go to the people working on them.
Matched in your browser only. The text is not sent, saved or logged.
Sources: ClinicalTrials.gov, EU CTR, OpenAlex, PubMed. Machine-matched links are labelled.